Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Caverject 10mcg Powder and Solvent for Solution for Injection - PA0822/115/002
- Caverject 20mcg Powder and Solvent for Solution for Injection - PA0822/115/003
- Cozatan 50mg Film Coated Tablets - PA0126/167/001
- Cozatan 100mg Film Coated Tablets - PA0126/167/002
- Cozatan Comp 50 mg/12.5mg Film Coated Tablets - PA0126/184/001
- Cozatan Comp 100 mg/25mg Film Coated Tablets - PA0126/184/002
- Ezetimibe Rowa 10mg Tablets - PA0074/074/001
- Losartan/Hydrochlorothiazide Teva 50mg/12.5mg Film Coated Tablets - PA0749/026/001
- Losartan/Hydrochlorothiazide Teva 100mg/25mg Film Coated Tablets - PA0749/026/002
- Oestrogel Pump Pack 750mcg/actuation Gel - PA1054/004/001
- Orencia 125mg Solution for Injection in Pre Filled Pen - EU/1/07/389/011
- Rosuvastatin 20mg Film Coated Tablets - PA2315/068/003
- Rosuvastatin 40mg Film Coated Tablets - PA2315/068/004
- Rowalief 500mg Film Coated Tablets - PA0074/065/001
- Sevelamer Carbonate 800mg Film Coated Tablets - PA0577/205/001
- Sodium Iodide (I131) Capsule T - PA0690/006/002
- Uniphyllin Continus 400mg Prolonged Release Tablets - PA1688/011/003
The following shortages have been resolved and supply has resumed to the Irish market:
- Androcur 100mg Tablets - PA1410/001/001
- Becotide Evohaler 50mcg, Pressurised Inhalation Solution - PA1077/042/006
- Catapres 100mcg Tablets - PA2256/003/001
- Ezetimibe/Simvastatin Krka 10mg/20mg Tablets - PA1347/067/002
- Geodon 80mg Hard Capsules - PA23055/015/004
- Innohep 8,000 IU in 0.4 ml, Solution for Injection - PA0046/060/012
- Magnesium Sulfate 50 % w/v Solution for Injection/Concentrate for solution for infusion (10ml presentation) - PA0549/020/001
- RoActemra 20mg/ml Concentrate for Solution for Infusion - EU/1/08/492/001-006
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.